Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
ME.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ME.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ME.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LE.1.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.49.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.49.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.49.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.49.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.15.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.15.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.441ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.441ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.441NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.509ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.509ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.509ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used